Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,339,133
  • Shares Outstanding, K 352,174
  • Annual Sales, $ 4,146 M
  • Annual Income, $ -260,000 K
  • EBIT $ 424 M
  • EBITDA $ 836 M
  • 60-Month Beta 0.43
  • Price/Sales 1.52
  • Price/Cash Flow 9.40
  • Price/Book 0.95

Options Overview Details

View History
  • Implied Volatility 49.83% ( -2.32%)
  • Historical Volatility 44.64%
  • IV Percentile 72%
  • IV Rank 47.31%
  • IV High 90.32% on 07/26/24
  • IV Low 13.47% on 05/14/24
  • Put/Call Vol Ratio 0.49
  • Today's Volume 718
  • Volume Avg (30-Day) 791
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 25,017
  • Open Int (30-Day) 21,156

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.23
  • Number of Estimates 8
  • High Estimate 0.27
  • Low Estimate 0.21
  • Prior Year 0.24
  • Growth Rate Est. (year over year) -4.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.71 +1.64%
on 12/11/24
20.71 -13.09%
on 12/10/24
-1.38 (-7.12%)
since 11/20/24
3-Month
17.71 +1.64%
on 12/11/24
21.69 -17.01%
on 10/14/24
-1.96 (-9.82%)
since 09/20/24
52-Week
13.16 +36.78%
on 05/02/24
21.69 -17.01%
on 10/14/24
+2.69 (+17.57%)
since 12/20/23

Most Recent Stories

More News
Bausch + Lomb: Q3 Earnings Snapshot

Bausch + Lomb: Q3 Earnings Snapshot

BLCO : 18.00 (+0.28%)
Why Bausch + Lomb Stock Soared by Over 7% on Monday

It was quite a busy and eventful day for the company.

BX : 170.84 (+1.14%)
BLCO : 18.00 (+0.28%)
TPG : 64.82 (+1.31%)
GS : 566.10 (+2.19%)
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.

ALC : 84.76 (+0.69%)
BLCO : 18.00 (+0.28%)
BHC : 7.47 (+1.08%)
Here's Why Bausch Health Stock Gained 14.7% in a Week

Shares of Bausch Health, Inc. BHC gained 14.7% in a week on reports of refinancing its debt to enable the impending sale of its eye care company, Bausch + Lomb BLCO. The industry declined 0.6% during this...

KRYS : 164.83 (+2.49%)
FULC : 4.35 (+7.94%)
BLCO : 18.00 (+0.28%)
BHC : 7.47 (+1.08%)
Why Bausch + Lomb Rallied Today

The highly indebted healthcare stock rose on rumors it may be selling itself.

BLCO : 18.00 (+0.28%)
Bausch + Lomb: Q2 Earnings Snapshot

Bausch + Lomb: Q2 Earnings Snapshot

BLCO : 18.00 (+0.28%)
This Bausch Health Companies Unusually Active Option Is a No-Brainer

Bausch Health Companies had the 8th-highest Vol/OI ratio in Wednesday trading. The pharmaceutical company’s unusual options activity suggests it might have more gains ahead.

BHC : 7.47 (+1.08%)
BLCO : 18.00 (+0.28%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END

OKYO : 1.0600 (-2.75%)
ALC : 84.76 (+0.69%)
BLCO : 18.00 (+0.28%)
JNJ : 144.47 (+0.62%)
RHHBY : 34.5000 (+0.76%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

/PRNewswire/ -- The Global Dry Eye Syndrome market has been growing substantially in the past years and is expected to continue through 2030. Dry Eye Syndrome...

OKYO : 1.0600 (-2.75%)
ALC : 84.76 (+0.69%)
BLCO : 18.00 (+0.28%)
JNJ : 144.47 (+0.62%)
RHHBY : 34.5000 (+0.76%)
Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...

BLCO : 18.00 (+0.28%)
BLCO.TO : 26.87 (+3.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R)....

See More

Key Turning Points

3rd Resistance Point 18.53
2nd Resistance Point 18.37
1st Resistance Point 18.18
Last Price 18.00
1st Support Level 17.83
2nd Support Level 17.67
3rd Support Level 17.48

See More

52-Week High 21.69
Fibonacci 61.8% 18.43
Last Price 18.00
Fibonacci 50% 17.42
Fibonacci 38.2% 16.42
52-Week Low 13.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar